Immunocore Holdings plc reported earnings results for the fourth quarter ended December 31, 2022. For the fourth quarter, the company reported revenue was GBP 48.06 million compared to GBP 6.59 million a year ago. Net loss was GBP 25.2 million compared to GBP 39.39 million a year ago.

Basic loss per share from continuing operations was GBP 0.54 compared to GBP 0.9 a year ago.